Asia Fresh News

Asia Fresh Stories

Archive for April 12th, 2013

Global Trends and Transitions Shaping the Future of Medical Imaging Equipment

leave a comment »

– Sustainability of medical imaging equipment revenue streams: a function of appropriate portfolio mix and customer targets in high growth markets
MOUNTAIN VIEW, Calif./PRNewswire/ —
WHEN: 11:00 a.m. EDT on Thursday, April 25, 2013
LOCATION: Online, with free registration
SPEAKER: Medical Imaging Industry Analyst Roberto Aranibar
Economic crises, austerity measures, and healthcare policy changes weighed heavily on global medical imaging equipment market expansion in recent years. Modest growth rates continue, largely due to rapid healthcare infrastructure developments and growing adoption of advanced imaging modalities in emerging market regions. To maximize potential for future success, stakeholders must be aware of key trends and transitions underway to prepare for and adapt to a new market environment.
Attend this webinar to discover:
Evaluate market potential for basic and advanced medical imaging modalities
Learn about important market characteristics and trends
Identify opportunities for growth in medical imaging equipment markets within each region of the world
Consider factors affecting market growth internationally
This briefing will benefit stakeholders in medical imaging equipment markets including vendors, suppliers and investors interested in understanding influential factors shaping the future of the market.
Supporting Quote
“Despite widespread economic crises and disruptive changes in healthcare policy within key developed markets, continued economic growth and healthcare infrastructure development in emerging markets is helping sustain modest growth levels,” said Frost & Sullivan Industry Analyst Roberto Aranibar. “Prompted by formidable challenges in developed markets, vendors are shifting their efforts and investments toward emerging markets, where providers continue transitioning to more advanced medical imaging technologies.”
Supporting Resources
For more information about Frost & Sullivan’s Advanced Medical Technologies practice, please visit: http://medtech.frost.com.
Registration
To attend the briefing, email britni.myers@frost.com your full name, job title, company name, company telephone number, company email address and website, city, state and country.
Receive a recorded version of the briefing anytime by submitting the aforementioned contact details.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion
Join Us: Join our community
Subscribe: Newsletter on “the next big thing”
Register: Gain access to visionary innovation
Contact:
Britni Myers
Frost & Sullivan
+1-210-477-8481
britni.myers@frost.com
Source: Frost & Sullivan

Written by asiafreshnews

April 12, 2013 at 11:49 am

Posted in Uncategorized

3VR and ObjectVideo Enter Into Global Video Analytics Patent License Agreement

leave a comment »

RESTON, Va. /PRNewswire/ — ObjectVideo, Inc., announced today that 3VR, the video intelligence company has joined the growing number of video analytics leaders as licensees of ObjectVideo’s patent-portfolio.
(Logo: http://photos.prnewswire.com/prnh/20130109/PH39430LOGO)
The agreement gives 3VR a global, portfolio-wide license to the full portfolio of ObjectVideo video analytics patents and ensures 3VR complete freedom to expand and grow its already broad portfolio of Video Intelligence and Automated Monitoring solutions for the life of the agreement.
“We are pleased to have entered into a global, portfolio-wide license agreement with 3VR, one of the early pioneers in the video analytics arena. They are a strong partner for OV, a pioneer in Video Intelligence, and a strong player in the intelligent VMS and Hybrid NVR marketplace,” said Raul Fernandez, chairman of ObjectVideo.
“This agreement provides certainty for our partners and customers and gives 3VR greater flexibility to continue to innovate and grow our Video Intelligence Platform, with an ever expanding plug-in library,” said Al Shipp, CEO, 3VR Inc.
3VR is the twelfth licensee to join ObjectVideo’s patent licensing program; other licensees include Panasonic, Sony Corporation, Pelco by Schneider Electric, Bosch Security Systems, Tyco Security Products’ American Dynamics business unit, IntelliVision, Aimetis, VIVOTEK and UDP. ObjectVideo holds 53 U.S. and international patents and has 44 U.S. and international patents pending.
About ObjectVideo, Inc.
ObjectVideo is a leading innovator in intelligent video software, utilized by organizations worldwide to enhance security, streamline operations and provide business intelligence. ObjectVideo’s patented technology can be effectively deployed anywhere within a video system and is available to market through leading providers as a high-value component of the surveillance solution. To stay up-to-date on ObjectVideo news, please click HERE.
About 3VR
3VR, the video intelligence company, enables organizations to search, mine and leverage video to bolster security, identify and mitigate fraud and better serves customers. 3VR’s Video Management Software, Network Video Recorders, and Video Analytics allow video surveillance systems to reach their true potential, and deliver a measurable and sustainable return on investment. 3VR is the video intelligence standard for hundreds of global customers, including leading banks, retailers, governments and law enforcement agencies and owns CrimeDex, an online community of thousands of fraud, loss prevention and law enforcement professionals dedicated to stopping crime. Visit http://www.3vr.com for more information.
CONTACT: Victoria Palley, Analyst, ObjectVideo, Inc., +1-703-654-9394, vblack@objectvideo.com
Source: ObjectVideo, Inc.

Written by asiafreshnews

April 12, 2013 at 11:41 am

Posted in Uncategorized

Extension of the Tender Offer for Securities of Maxcom

leave a comment »

MEXICO CITY /PRNewswire/ — Ventura Capital Privado S.A. de C.V. (“Ventura”), on behalf of Trust Number 1387 (the “Trust” and, collectively with Ventura, Javier Molinar Horcasitas and Enrique Castillo Sanchez Mejorada, the “Purchaser”), today announced that the Purchaser has extended the expiration date of its tender offer to purchase (i) all of the outstanding Series A Common Stock, without par value (the “Shares”) of Maxcom Telecomunicaciones, S.A.B. de C.V. (“Maxcom”), (ii) all of the outstanding Ordinary Participation Certificates (“CPOs”) of Maxcom, and (iii) all of the outstanding American Depository Shares (“ADSs,” and collectively with the Shares and CPOs, the “Securities”) of Maxcom, in each case held by persons who are not Mexican residents (the “tender offer” or “U.S. Offer”). In Mexico (the “Mexican Offer,” and collectively with the U.S. Offer, the “Equity Tender Offer”), the Purchaser is offering to purchase all of the outstanding Shares and CPOs of Maxcom. The Mexican Offer is being made on substantially the same terms and at the same prices as the U.S. Offer.
The tender offer, which was previously scheduled to expire at 12:00 midnight, New York time, on April 10, 2013, will now expire at 12:00 midnight, New York City time, on April 24, 2013, unless further extended in accordance with the terms of the tender offer. The closing of the tender offer will occur on April 29, 2013. The extension to April 24, 2013 was made to accommodate the timetable for the simultaneous exchange offer for any and all outstanding Maxcom’s 11% Senior Notes due 2014 for Maxcom’s Step-Up Senior Notes due 2020 (“Exchange Offer”).
In addition, the Purchaser is also amending and supplementing the tender offer to reflect that Maxcom, according to a press release issued on April 10, 2013, has stated that (i) Maxcom has increased the minimum tender condition in the Exchange Offer from 61.44% to 80%, subject to Maxcom’s right, in its sole discretion, to decrease the minimum tender condition to 75.1% without extending the Exchange Offer or granting withdrawal rights; (ii) the Exchange Offer has been extended three times and as a result has remained open longer than anticipated; (iii) since the Exchange Offer and the Equity Tender Offer have not been consummated to date, Maxcom has not yet received the capital contribution the Purchaser agreed to make in connection with the Equity Tender Offer; (iv) during the period that the Exchange Offer has remained open, Maxcom’s operational and financial viability has further deteriorated in light of not having received the capital contribution from the Purchaser; (v) as of March 1, 2013, Maxcom’s cash and temporary investment balance was Ps.82.8 million (US$6.4 million); (vi) if the Exchange Offer is not consummated and Maxcom does not receive the capital contribution from the Purchaser in connection with the Equity Tender Offer, Maxcom does not expect to be able to make the coupon payment due on June 15, 2013 with respect to the Old Notes and Maxcom may not be able to meet other financial obligations as they come due; (vii) if this occurs, holders of the Old Notes and the creditors could commence involuntary bankruptcy proceedings against Maxcom in Mexico or in the United States; and (viii) if the Exchange Offer is not consummated, Maxcom currently intends to implement a restructuring by (a) commencing voluntary cases under Chapter 11 of the United States Bankruptcy Code through a plan of reorganization; (b) seeking expedited confirmation of a plan of reorganization or (c) seeking other forms of bankruptcy relief, all of which involve uncertainties, potential delays, reduced payments to all creditors (including holders of the Old Notes) and litigation risks. Moreover, Maxcom has also stated that (i) such a restructuring may be protracted and contentious and disruptive to Maxcom’s business and could materially adversely affect Maxcom’s relationships with its customers, suppliers and employees who may terminate their relationships with Maxcom; (ii) a restructuring would also cause Maxcom to incur significant legal, administrative and other professional expenses; (iii) no assurances can be given that any such restructuring will be successful or that holders of Maxcom’s debt obligations will not have their claims significantly reduced, converted into equity or eliminated; (iv) if a restructuring is not successful, Maxcom may be forced to liquidate its business and assets; (v) the board of directors of Maxcom has approved the engagement of, and the Maxcom has engaged, counsel to advise it on a Chapter 11 reorganization and authorized the preparatory activities related to a restructuring, including the negotiating of a plan support agreement and a Chapter 11 plan term sheet with certain of the holders of the Old Notes during the pendency of the Exchange Offer; and (vi) in the event Maxcom implements a restructuring through Chapter 11, holders of the Old Notes may receive New Notes with terms less favorable than those offered pursuant to the Exchange Offer .
The depositary for the Equity Tender Offer has advised the Purchaser in connection with the Equity Tender Offer that as of 5:00 p.m., New York City time, on April 10, 2013, approximately 354,540,391 of Maxcom’s Series A Common Stock, or 44.87% of the total outstanding Series A Common Stock, had been validly tendered and not withdrawn in the Equity Tender Offer.
Additional Information and Where to Find It
This communication is neither an offer to purchase nor a solicitation of an offer to sell any Securities. This communication is for informational purpose only. The tender offer is not being made to, nor will tenders be accepted from, or on behalf of, holders of Securities in any jurisdiction in which the making of the tender offer or the acceptance thereof would not comply with the laws of that jurisdiction. The Purchaser has filed a tender offer statement on Schedule TO-T, as amended, including an offer to purchase, a letter of transmittal and related documents, with the Securities and Exchange Commission (“SEC”). The offer to purchase the Securities is only being made pursuant to the offer to purchase, the letter of transmittal and related documents filed with such tender offer statement. Security holders should read those materials carefully because they contain important information, including the various terms and conditions of the tender offer. Security holders of Maxcom may obtain a free copy of these documents and other documents filed by the Trust and Maxcom with the SEC at the website maintained by the SEC at http://www.sec.gov. In addition, stockholders may obtain a free copy of these documents from the Purchaser by contacting Georgeson Inc., the Information Agent for the tender offer, at +1-(866)-729-6818 or by contacting Maxcom’s Investor Relations department at +(52-55)-4770-1170.
Source: Ventura Capital Privado S.A. de C.V.

Written by asiafreshnews

April 12, 2013 at 11:01 am

Posted in Uncategorized

MAQUET Cardiovascular Receives FDA 510(k) Clearance and CE Mark Approval for AIR-BAND(TM) Radial Compression Device

leave a comment »

— Device Expands MAQUET’s Portfolio of Hemostasis Devices —
WAYNE, N.J. /PRNewswire/ — MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and European CE mark approval for its new AIR-BAND™Radial Compression Device. Indicated to assist hemostasis of the radial artery after a transradial procedure, the device is designed to compress the radial artery puncture site while maintaining site visibility and a secure fit around the wrist. AIR-BAND will be commercially available in the European Union later this month and in the United States in April.
“We have found that AIR-BAND is easy to use, reliable and effective in achieving hemostasis following radially accessed coronary catheterization procedures,” said Christian Valina, M.D., interventional cardiologist at the University Heart Centre of Bad Krozingen in Germany. “My colleagues and I were impressed by the secure fit around the wrist that the adhesive band provides. We believe that AIR-BAND represents important progress towards ensuring patient safety and comfort during these important procedures.” Similar positive feedback has also been received from other sites in the EU and USA.
“Drawing on our significant experience in hemostasis management, we designed AIR-BAND to provide all the valued benefits of our SAFEGUARD® Pressure Assisted Device — which assists in obtaining and maintaining hemostasis after a femoral procedure — and applied our knowledge to a radial application,” said Christian Keller, President and Chief Executive Officer of MAQUET Cardiovascular. “Both devices simplify hemostasis management by delivering hands-free adjustable pressure, offering simple application and removal, and providing clear site visibility and assessment without compromising patient comfort, which is a priority for us.”
About AIR-BAND
AIR-BAND is a 26-cm long, latex-free, self-adhesive wristband with a clear window and bulb that facilitate visualization of the puncture site. A luer valve on the end of the clear fill tube enables any standard syringe to be connected to inflate and deflate the bulb with air to provide compression of the radial puncture site.
With its textile wristband, AIR-BAND contributes to patient comfort, as it neither cuts into the skin nor has protruding plastic parts. The adhesive enables a secure fit around all patient wrists, avoiding movement and dislocation. Both the size and shape of AIR-BAND’s inflatable bulb minimize the compression risk to surrounding nerve structures or areas other than the radial puncture site. The standard luer valve allows easy inflation and deflation with any standard luer syringe.
About MAQUET
MAQUET, a trusted partner for hospitals and physicians for over 175 years, is the global leader in providing medical systems that meet the needs of the most medically challenging patients, while exceeding the expectations of the hospital teams that care for them. MAQUET designs, develops and distributes innovative therapy solutions and infrastructure capabilities for high-acuity areas within the hospital including the operating room (OR), hybrid OR/cath lab and intensive care unit (ICU) as well as intra and inter hospital patient transport.
Headquartered in Rastatt, Germany, MAQUET is the largest subsidiary of the publicly listed Getinge Group AB of Sweden. MAQUET generated about 1.5 billion Euros in 2012, representing more than half of the Getinge Group’s annual revenue of 2.7 billion Euros. MAQUET has 6,300 employees in 45 international sales and service organizations, as well as a network of more than 300 sales representatives. For more information please visit http://www.maquet.com.
MAQUET – The Gold Standard
http://www.maquet.com
http://www.getingegroup.com
Source: MAQUET Cardiovascular LLC

Written by asiafreshnews

April 12, 2013 at 10:29 am

Posted in Uncategorized

Purchasers of Freight Forwarding Services Could be Affected by a Class Action Lawsuit

leave a comment »

WASHINGTON/PRNewswire/ — The following class-action Settlements have been preliminarily approved by the United States District Court for the Eastern District of New York and are being announced by the law firms of Cotchett, Pitre & McCarthy, LLP; Gustafson Gluek, PLLC; Lockridge Grindal Nauen P.L.L.P and Lovell, Stewart, Halebian, Jacobson LLP:
Proposed Settlements have been reached in a class action lawsuit, which claims that freight forwarders throughout the world conspired to fix prices for their services, including on routes between the U.S. and Mainland China, Hong Kong, Japan, Taiwan, and the U.K. Some of the companies who were sued have agreed to settlements. These “Settling Defendants” are:
ABX Logistics Worldwide NV/SA;
EGL, Inc. and EGL Eagle Global Logistics;
Expeditors International of Washington, Inc.;
Kuehne + Nagel International AG and Kuehne + Nagel, Inc.;
Nishi-Nippon Railroad Co., Ltd.
Schenker, Inc. and its parents, subsidiaries, and affiliates, including Deutsche Bahn AG, Schenker AG, and BAX Global, Inc.; and
Morrison Express Logistics Pte. (Singapore) and Morrison Express Corporation (U.S.A.);
United Aircargo Consolidators, Inc.;
UTi Worldwide, Inc.; and
Vantec Corporation and Vantec World Transport (USA), Inc.
The lawsuit will continue against those companies that have not settled (“Non-Settling Defendants”). A list of the Non-Settling Defendants is available at http://www.FreightForwardCase.com.
Individuals and businesses are included in one or more of the Settlements if they: a) Directly purchased Freight Forwarding Services; b) From any of the Settling or Non-Settling Defendants, their subsidiaries, or affiliates; c) From January 1, 2001 through September 14, 2012, d) In the U.S., or outside the U.S. for shipments within, to, or from the U.S.
“Freight Forwarding Services” means freight forwarding, transportation, or logistics services for shipments, including services relating to the organization or transportation of items via air, ocean, rail, and road, both nationally and internationally, and related activities such as customs clearance, warehousing, and ground services.
Class Members have a choice of whether or not to stay in the Class. If Class Members choose to stay in the Class, they will be legally bound by all orders and judgments of the Court, and they will not be able to sue, or continue to sue, the Settling Defendants for the issues involved in this lawsuit. Class Members who choose to stay in the Class may object to all or part of one or more of the Settlements.
In order to receive the benefits of these settlements, Class Members must submit a Claim Form online or by mail by November 22, 2013. Some Class Members will have received a notice packet in the mail containing a Claim Form. For those who did not receive a notice packet in the mail, they can submit a Claim Form at http://www.FreightForwardCase.com. They may also contact the Claims Administrator to request a Claim Form be mailed to them by calling 1-877-276-7340 (in the U.S. or Canada) or 503-520-4400 (outside the U.S. or Canada) or writing to the following address:
Freight Forwarders Claims Administrator
P.O. Box 3747
Portland, Oregon 97208-3747
For more information regarding this lawsuit and Class Member rights, including how Class Members can exclude themselves and how to get a copy of a detailed notice, please visit http://www.FreightForwardCase.com, call 1-877-276-7340, or write to: Freight Forwarders Claims Administrator, P.O. Box 3747, Portland, OR, 97208-3747.
Source: Cotchett, Pitre & McCarthy, LLP; Gustafson Gluek, PLLC; Lockridge Grindal Nauen P.L.L.P and Lovell, Stewart, Halebian, Jacobson LLP

Written by asiafreshnews

April 12, 2013 at 10:10 am

Posted in Uncategorized